Literature DB >> 26152497

Hypercoagulable state evaluated by thromboelastography in patients with idiopathic membranous nephropathy.

Meng-jie Huang1, Ri-bao Wei2, Qing-ping Li1, Xi Yang1, Cui-ming Cao1, Ting-yu Su1, Na Wang1, Rui Wang1, Xiang-mei Chen1.   

Abstract

The aims of this study were to evaluate the characteristics of hypercoagulable states in patients with membranous nephropathy (MN) via thromboelastography (TEG) and to identify risk factors. 235 MN patients who had undergone TEG examinations from 2011 to 2014 were included. An abnormality in at least two TEG parameters is considered a hypercoagulable state. Patient data was compared between the hypercoagulable and non-hypercoagulable groups. Potential risk factors for hypercoagulability were analyzed by logistic regression models. Subgroup analysis was performed in hypercoagulable patients. Compared to the non-hypercoagulable MN patients, the hypercoagulable patients showed a significantly higher proportion of female patients, urinary protein, platelet count, triglyceride and fibrinogen level, along with more severe hypoproteinemia and a reduction of serum antithrombin III. Correlation analysis showed that hypoproteinemia was the primary risk factor for hypercoagulability in MN patients. Among the hypercoagulable MN patients, a subgroup TEG parameter analysis showed that glucocorticoids-used subgroup and smoker subgroup had shortened time to initial fibrin formation (R value) and increased coagulation index respectively (P < 0.05), indicating a more serious hypercoagulable state. Meanwhile, the time to initial fibrin formation (R value) and time to clot formation (K value) of the statin-used patients were remarkably higher than those of the non-statin patients. TEG examinations facilitated the detection of hypercoagulable states in MN patients, and hypoproteinemia was the most important risk factor for hypercoagulability in these patients. The use of glucocorticoids and smoking may help to aggravate hypercoagulable states, while statin drugs may alleviate hypercoagulability.

Entities:  

Keywords:  Hypercoagulable state; Hypoproteinemia; Membranous nephropathy; Thromboelastography

Mesh:

Year:  2016        PMID: 26152497     DOI: 10.1007/s11239-015-1247-x

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  25 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Statin use in patients with nephrotic syndrome is associated with a lower risk of venous thromboembolism.

Authors:  Mohammad Resh; Bakhtawar K Mahmoodi; Gerjan J Navis; Nic J G M Veeger; Willem M Lijfering
Journal:  Thromb Res       Date:  2011-01-31       Impact factor: 3.944

3.  Usefulness of thrombelastography in assessment of trauma patient coagulation.

Authors:  C R Kaufmann; K M Dwyer; J D Crews; S J Dols; A L Trask
Journal:  J Trauma       Date:  1997-04

Review 4.  Thrombelastography/thromboelastometry.

Authors:  R J Luddington
Journal:  Clin Lab Haematol       Date:  2005-04

Review 5.  Thrombelastography.

Authors:  Håkon Reikvam; Egil Steien; Bjørn Hauge; Knut Liseth; Kristin Gjerde Hagen; Rolf Størkson; Tor Hervig
Journal:  Transfus Apher Sci       Date:  2009-02-26       Impact factor: 1.764

6.  In normal controls, both age and gender affect coagulability as measured by thrombelastography.

Authors:  Wilfried W H Roeloffzen; Hanneke C Kluin-Nelemans; Andre B Mulder; Nic J G M Veeger; Lotte Bosman; Joost Th M de Wolf
Journal:  Anesth Analg       Date:  2010-04-01       Impact factor: 5.108

Review 7.  Why is everyone so excited about thromboelastrography (TEG)?

Authors:  Brad S Karon
Journal:  Clin Chim Acta       Date:  2014-05-28       Impact factor: 3.786

8.  Hypercoagulability is most prevalent early after injury and in female patients.

Authors:  Martin A Schreiber; Jerome Differding; Per Thorborg; John C Mayberry; Richard J Mullins
Journal:  J Trauma       Date:  2005-03

9.  Normal range values for thromboelastography in healthy adult volunteers.

Authors:  S Scarpelini; S G Rhind; B Nascimento; H Tien; P N Shek; H T Peng; H Huang; R Pinto; V Speers; M Reis; S B Rizoli
Journal:  Braz J Med Biol Res       Date:  2009-10-30       Impact factor: 2.590

10.  Prophylaxis with AT III for thromboembolism in nephrotic syndrome: why should it be done?

Authors:  Marco Zaffanello; Milena Brugnara; Vassilios Fanos; Massimo Franchini
Journal:  Int Urol Nephrol       Date:  2008-08-12       Impact factor: 2.370

View more
  4 in total

1.  Nephrotic syndrome disease activity is proportional to its associated hypercoagulopathy.

Authors:  Amanda P Waller; Jonathan P Troost; Samir V Parikh; Katelyn J Wolfgang; Brad H Rovin; Marvin T Nieman; William E Smoyer; Matthias Kretzler; Bryce A Kerlin
Journal:  Thromb Res       Date:  2021-02-16       Impact factor: 3.944

2.  Characterization of thromboelastography of patients with different pathological types of nephrotic syndrome.

Authors:  Chunlei Lu; Ke Zuo; Weibo Le; Wencui Chen; Weisong Qin; Fan Zhang; Shaoshan Liang; Caihong Zeng; Jinquan Wang
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

3.  [Perioperative Venous Thromboembolism (VTE) Prophylaxis in Thoracic Cancer Patients: Chinese Experts Consensus - Interpretation of Perioperative Hypercoagulable State].

Authors:  Songping Cui; Hui Li
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2019-12-20

4.  Comprehensive coagulation and fibrinolytic potential in the acute phase of pediatric patients with idiopathic nephrotic syndrome evaluated by whole blood-based rotational thromboelastometry.

Authors:  Tomoaki Ishikawa; Yuto Nakajima; Takashi Omae; Kenichi Ogiwara; Keiji Nogami
Journal:  Pediatr Nephrol       Date:  2022-01-08       Impact factor: 3.651

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.